National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1720747

Government Disclaimer on use of this data

Case Details

VAERS ID: 1720747 (history)  
Form: Version 2.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Cough, Drug hypersensitivity, Dyspnoea, Erythema, Hyperaesthesia, Lymphadenopathy, Neck pain, Rash
SMQs:, Anaphylactic reaction (narrow), Angioedema (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Immunodeficiency; Rash
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC202101168327

Write-up: Red, hot and sore rash on either side of neck; cough; Cough affecting breathing; sore rash on either side of neck/pressure at front of neck; hypersensitivity; Swollen lymph nodes; Neck rash; Hypersensation skin; This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202109062125091930-QD7KI. A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Sep2021 (Lot/batch number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included immunodeficiency and rash, both from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced Red, hot and sore rash on either side of neck, cough, cough affecting breathing, sore rash on either side of neck/pressure at front of neck and hypersensitivity on an unspecified date; neck rash and swollen lymph nodes on 05Sep2021; and hypersensation skin on 04Sep2021. The events were assessed as serious (medically significant). The outcome of the events ''neck rash'', ''hypersensation skin'' and ''swollen lymph nodes'' was not recovered and outcome of the other events was unknown. The clinical course was reported as follows: Red, hot and sore rash on either side of neck. Spread overnight towards front of neck plus pressure at front of neck. Swollen lymph nodes. Cough affecting breathing. Confirmed hypersensitivity caused by Pfizer. Medical staff said immune system went into overdrive. Patient has not tested positive for COVID-19 since having the vaccine. Patient was not enrolled in clinical trial. Additional information: Patient has not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient was not pregnant. Patient was not currently breastfeeding. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166